CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico,
AUTOR(ES)
Salinas-Santander, Mauricio Andrés; Cantu-Salinas, Cristina Susana; Ocampo-Candiani, Jorge; Suarez-Valencia, Victor de Jesus; Ramirez-Guerrero, Jennifer Guadalupe; Sanchez-Dominguez, Celia Nohemi
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2020-06
RESUMO
Abstract Background: Alopecia areata is an autoimmune disease that produces non-scarring hair loss around the body. Gene variants of the cytotoxic T-lymphocyte antigen 4 (CTLA4) gene, a negative regulator of T-cell response, have been associated with a predisposition to autoimmune diseases in different populations; however, the involvement of these genetic variants in the development of AA is controversial. Objective: The present study evaluated the potential association of two CTLA4 gene variants with alopecia areata in a Mexican population. Methods: We genotyped +49AG (rs231775) and CT60 (rs3087243) variants in 50 AA patients and 100 healthy control participants through PCR-RFLP. Results: No statistical difference was observed for either of the gene variants regarding allele or genotype frequencies between AA patients and the controls when the parameters of family/personal history of autoimmune diseases or gender were considered (p > 0.05). Study limitations: Small sample size of patients and the data were obtained from Northeast Mexico population. Conclusion: The genetic variants rs231775 and rs3087243 of the CTLA4 gene are not a risk factor for the development of alopecia areata in the analyzed Mexican population.
Documentos Relacionados
- Association between the CTLA4 +49A/G (rs231775) and CT60 (rs3087243) gene variants with vitiligo: study on a Mexican population
- CTLA4 CT60 gene polymorphism is not associated with differential susceptibility to pemphigus foliaceus
- CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population
- Antiviral immune responses in CTLA4 transgenic mice.
- Dinucleotide repeat polymorphism at the human CTLA4 gene